Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stockholm - Free Realtime Quote • SEK Spago Nanomedical AB (publ) (SPAGO.ST) Follow Compare 0.2180 -0.0010 (-0.46%) As of 11:23:56 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for SPAGO.ST 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: SPAGO.ST View More All News Press Releases SEC Filings Notice To Annual General Meeting of Spago Nanomedical AB (PUBL) Nomination Committee's Proposal for a New Chairman and Composition of Spago Nanomedical’s Board Spago Nanomedical Proceeds with Increased Dose in the Phase I/IIa study Tumorad-01 Spago Nanomedical year-end report January-December, 2024 Spago Nanomedical Article on SPAGOPIX-01 Clinical Results Accepted for Publication in Investigative Radiology Second Patient Group Successfully Dosed in Spago Nanomedical's Phase I/IIa Study Tumorad-01 Spago Nanomedical Interim Report January-September 2024 Nomination Committee Appointed for Spago Nanomedical’s Annual General Meeting 2025 Spago Nanomedical in New Phase with Full Focus on the Tumorad Program Spago Nanomedical's Phase I/IIa Study Tumorad-01 Continues Following Successful Treatment Completion of First Patient Group Spago Nanomedical Interim Report January-June 2024 Related Tickers OBIO Orchestra BioMed Holdings, Inc. 2.8000 -6.04% CUV.AX Clinuvel Pharmaceuticals Limited 10.76 +0.19% MEIP MEI Pharma, Inc. 1.9100 +2.14% IDIA.SW Idorsia Ltd 1.1100 +5.11% CLLS Cellectis S.A. 1.5000 +4.17%